BNTX: BioNTech SE O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
GURU.Markets grafigidagi PEG past baholanganlik darajasi COVID-19ga qarshi dori vositalaridan tushadigan foydaning kamayishi va yangi mahsulotlarga bo'lgan bog'liqlik ta'sirini ko'rsatadi, bunda 0.00 joriy metrika ko'rsatkichi bo'lib xizmat qiladi. Ushbu pasayish mablag'larning onkologiya sektoriga qayta taqsimlanishi va mRNA terapiyasining kengayishi bilan bog'liq. Immunologiya sohasidagi kashfiyotchi sifatida BioNTech SE (BNTX) kompaniyasining global nufuzi ushbu ilmiy yutuqlarga bo'lgan ishonchni saqlab qoladi.
BioNTech SE (BNTX) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati BioNTech SE|BNTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi biontech.de|BNTX - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar BioNTech Group|BNTX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi BioNTech|Oraliq qoplama koeffitsiyenti biontech.de
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
BNTX - Kompaniyaning sof foydasi|Kutilayotgan sof foyda BioNTech SE|BNTX - Narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati BioNTech Pharma|BNTX - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti BioNTech Group|BNTX - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda BioNTech|BNTX - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi biontech.de|BNTX - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi BioNTech SE
Kompaniyaning umumiy tahlili:BNTX - BioNTech Inc.
BioNTech SE (BNTX) kompaniyasining COVID bilan bog'liq daromadlar pasayishi fonida onkologik vaksinalarga o'tishi bozor qiymatini foyda o'sishi bilan solishtirishni muhim qiladi. P/E koeffitsiyentini foyda o'sish sur'atiga bo'luvchi ushbu nisbat aktiv narxining adolatli ekanligini belgilaydi: birdan past qiymatlar o'sish potentsialining yetarlicha baholanmaganligidan dalolat beradi, bu esa tarixiy P/E-o'sish tendentsiyasida aniq aks etgan.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ABVX (abivax.com)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati ADMA Corp (ADMA)|PTGX - Narxning foydaga va o‘sish sur’atiga nisbati|immunovant.com (IMVT) - Narx-foyda va o‘sish multiplikatori|Kiniksa (KNSA) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Grifols SA|Narx-foyda va o‘sish multiplikatori ADPT|PEG multiplikatori Celldex Corp|Narxning foydaga va o‘sish sur’atiga nisbati Aurinia Pharmaceuticals (AUPH)|biocryst.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - O‘sish sur’atiga tuzatilgan narx-foyda|Pharvaris Corp - PEG multiplikatori|ABCL: Narxning foydaga va o‘sish sur’atiga nisbati|TRML: PEG multiplikatori|PGEN - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Pharming Group|O‘sish sur’atiga tuzatilgan narx-foyda Nektar Therapeutics Inc NKTR|Narxning foydaga va o‘sish sur’atiga nisbati Upstream Bio Corp (UPB)|Zenas Corp - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Immunome, Inc. - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati GOSS (gossamerbio.com)|KalVista Pharmaceuticals, Inc. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Septerna, Inc.|PVLA: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Savara Pharma|RIGL (Rigel Pharmaceuticals) - PEG multiplikatori|ANAB: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori ATXS (Astria Therapeutics, Inc.)|ENGN (enGene Holdings Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati RAPT Therapeutics, Inc. RAPT|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Aerovate Therapeutics, Inc. (JBIO)|Aclaris Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda kyvernatx.com|TLSA: PEG multiplikatori|CABA (Cabaletta Bio Inc.) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Ventyx Bio|O‘sishni hisobga olgan narx-foyda koeffitsiyenti THTX (Theratechnologies, Inc)|Narx-foyda va o‘sish multiplikatori AVTX (Avalo Therapeutics, Inc)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati ELDN|Agenus Inc. - Narx-foyda va o‘sish multiplikatori|CLYM: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ZURA - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati ATYR|ADAG: PEG multiplikatori|Ikena Oncology - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|STTK (Shattuck Labs Inc) - PEG multiplikatori|PEG multiplikatori Equillium Bio|Narxning foydaga va o‘sish sur’atiga nisbati Connect Biopharma (CNTB)|IMUX (immunic-therapeutics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Atara Bio ATRA|IFRX - Narx-foyda va o‘sish multiplikatori|X4 Pharmaceuticals, Inc. - PEG multiplikatori|ACET - PEG multiplikatori|CELU (celularity.com) - Narx-foyda va o‘sish multiplikatori|INmune Bio Corporation - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|BRNS (Barinthus Biotherapeutics) - PEG multiplikatori|kezarlifesciences.com (KZR) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|Narx-foyda va o‘sish multiplikatori Akari Therapeutics PLC AKTX|Narxning foydaga va o‘sish sur’atiga nisbati Enlivex Therapeutics Ltd. ENLV|QTTB - Narx-foyda va o‘sish multiplikatori|GOVX: Narx-foyda va o‘sish multiplikatori|EDSA - PEG multiplikatori|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CARM|XTLB (XTL Biopharmaceuticals, Ltd.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Bolt Bio BOLT|PEG multiplikatori HCWB|Narxning foydaga va o‘sish sur’atiga nisbati APVO (aptevotherapeutics.com)|PEG multiplikatori AIM (AIM ImmunoTech)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Aditxt Inc. (ADTX)|GRI - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda XORTX Corp|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti REVB|Narx-foyda va o‘sish multiplikatori INDP|SCNI (Scinai Immunotherapeutics Ltd) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori CALI|AFMD - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori ALLK (Allakos)|HOOK - Narx-foyda va o‘sish multiplikatori|IGM Bio - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ITOS (iTeos Therapeutics Inc)|OCEA (Ocean Bio) - Narx-foyda va o‘sish multiplikatori|TC BioPharm Ltd - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
